From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors

Overview of attention for article published in Frontiers in Chemistry, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 6,751 followers.

RT @CaroMedChem: 👋Our new publication on RIPK-1 inhibitor is out ! Take a look if you want to see how small pharmacomodulations allowed u…

RT @CaroMedChem: 👋Our new publication on RIPK-1 inhibitor is out ! Take a look if you want to see how small pharmacomodulations allowed u…

RT @CaroMedChem: 👋Our new publication on RIPK-1 inhibitor is out ! Take a look if you want to see how small pharmacomodulations allowed u…

RT @CaroMedChem: 👋Our new publication on RIPK-1 inhibitor is out ! Take a look if you want to see how small pharmacomodulations allowed u…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.